Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma

As the most common type of renal cell carcinoma (RCC), the renal clear cell carcinoma (ccRCC) is highly malignant and insensitive to chemotherapy or radiotherapy. Although systemic immunotherapies have been successfully applied to ccRCC in recent years, screening for patients who can benefit most fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Tang, Hanmin, Luo, Xuehui, Chen, Jie, Zhang, Xinyue, Li, Xinyue, Li, Yuesen, Chen, Yuetong, Xu, Yungang, Han, Suxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171405/
https://www.ncbi.nlm.nih.gov/pubmed/35686121
http://dx.doi.org/10.3389/fimmu.2022.890150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171405/
https://www.ncbi.nlm.nih.gov/pubmed/35686121
http://dx.doi.org/10.3389/fimmu.2022.890150

Ejemplares similares